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Rhizomelic chondrodysplasia punctata (RCDP) is a developmental disorder characterized by hypotonia, cat-
aracts, abnormal ossification, impaired motor development, and intellectual disability. The underlying etiol-
ogy of RCDP is a deficiency in the biosynthesis of ether phospholipids, of which plasmalogens are the most 
abundant form in nervous tissue and myelin; however, the role of plasmalogens in the peripheral nervous 
system is poorly defined. Here, we used mouse models of RCDP and analyzed the consequence of plasmalogen 
deficiency in peripheral nerves. We determined that plasmalogens are crucial for Schwann cell development 
and differentiation and that plasmalogen defects impaired radial sorting, myelination, and myelin structure. 
Plasmalogen insufficiency resulted in defective protein kinase B (AKT) phosphorylation and subsequent sig-
naling, causing overt activation of glycogen synthase kinase 3β (GSK3β) in nerves of mutant mice. Treatment 
with GSK3β inhibitors, lithium, or 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) restored 
Schwann cell defects, effectively bypassing plasmalogen deficiency. Our results demonstrate the requirement 
of plasmalogens for the correct and timely differentiation of Schwann cells and for the process of myelination. 
In addition, these studies identify a mechanism by which the lack of a membrane phospholipid causes neuro-
pathology, implicating plasmalogens as regulators of membrane and cell signaling.
Introduction
Plasmalogens, glycerophospholipids with a 1-O-alkenyl ether 
bond at the sn-1 position of the glycerol backbone, represent the 
most abundant form of ether phospholipids. In vitro studies 
have highlighted the role of plasmalogens as mediators of the 
physical properties of membranes, as antioxidants, and as pools 
of lipid mediators (1). The biosynthesis of ether phospholipids 
is initiated in peroxisomes by the activity of glyceronephosphate 
O-acyltransferase (GNPAT) and alkylglyceronephosphate syn-
thase (AGPS) (2). Mutations in GNPAT, AGPS, or in PEX7, which 
targets AGPS in peroxisomes, lead to extremely reduced levels 
of plasmalogens and to rhizomelic chondrodysplasia punctata 
(RCDP) (3–5). RCDP is a peroxisomal disorder characterized by 
multiple tissue defects, ranging from bone, eye, and heart, to ner-
vous tissue involvement (6, 7). Nevertheless, the pathophysiology 
behind defective plasmalogens is poorly understood. The pheno-
type of mouse models for RCDP has supported the etiology of 
the disease (8). Pex7- and Gnpat-KO mice, lacking plasmalogens 
in all tissues, are characterized by a severe phenotype, with early 
postnatal death and hypotonia in a subset of mice, whereas KO 
mice surviving past the first 2 weeks display impaired growth, 
cataracts, and infertility (9, 10). Decreased transcript levels of 
Pex7 and Agps impair ether phospholipid synthesis in Pex7 and 
Agps hypomorphic mice, respectively, causing partial decreases 
in plasmalogen levels. In these mutants, the residual levels of 
plasmalogens are thought to prevent the hypotonia and early 
lethality observed in KO mice (11, 12). Nevertheless, bone, lens, 
and testicular defects in the hypomorphic mice mirror those of 
KO mice. Pex7- and Gnpat-KO mice, models of RCDP type 1 and 
type 2, respectively, share a defect in ether phospholipid biosyn-
thesis, although Pex7-KO mice also have defects in fatty acid 
β- and α-oxidation (9, 13). As in the human RCDP variants, the 
phenotype and tissue pathology of Pex7- and Gnpat-KO mice are 
extremely similar, highlighting that the defect in plasmalogens is 
the major player in disease presentation and progression.
Plasmalogens are enriched in nervous tissue, especially in white 
matter, where they localize to the cytoplasmic apposition of mye-
lin (14, 15). Brain imaging of classical RCDP patients indicates 
impaired myelination, with hypointensity on T1-weighted images 
and reduced levels of choline, with increased mobile lipids and 
myo-inositol on MR spectroscopy (6, 16). A plasmalogen defi-
ciency in mice contributes to astrocytosis, microgliosis, and mye-
lin loss in the CNS (13). Impaired peripheral nerve conduction in 
Pex7-KO mice (13) and the description of peripheral neuropathy 
in a subset of RCDP patients lacking the rhizomelia and ossifica-
tion defects (17) prompted us to determine the role of plasmal-
ogens and the consequences of their deficiency in the peripheral 
nervous system (PNS). In the PNS, Schwann cells are the glia 
responsible for maintaining axonal health and myelination (18). 
Prior to myelination and concomitant with Schwann cell differ-
entiation, large-caliber axons destined for myelination are seg-
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regated from axon bundles by Schwann cells in a process called 
radial sorting (19). Differentiated, promyelinating Schwann cells 
then undergo transcriptional, biochemical, and morphologic 
changes as they initiate axonal wrapping with a myelin sheath 
(20, 21). In the PNS, the extent of myelin deposition around indi-
vidual axons is driven by the axonal expression of neuregulin 1 
(NRG1) and by the signaling cascade initiated in Schwann cells 
expressing the ErbB receptors (22). In the adult PNS, Remak bun-
dles are composed of immature, nonmyelinating Schwann cells 
that continue to associate with bundles of small-caliber axons 
that did not undergo radial sorting (23).
Here, we investigated the role of plasmalogens in myelination 
of the PNS. Our results demonstrate that plasmalogens are cru-
cial for Schwann cell differentiation, as their absence impairs 
axonal sorting and myelination. Moreover, we found that plas-
malogens and myelin basic protein (MBP) are two crucial play-
ers that coordinate myelination in the PNS. Mechanistically, 
we demonstrate that plasmalogens are essential for the correct 
phosphorylation and activation of protein kinase B (AKT). In 
mutant sciatic nerves, reduced AKT activity resulted in overt 
activation of glycogen synthase kinase 3β (GSK3β). Finally, we 
found that the exogenous inhibition of GSK3β with lithium or 
Figure 1
Plasmalogen deficiency causes defects in axonal sorting and myelination. (A) Electron microscopic analysis of sciatic nerves from P5 and 
P15 WT and Gnpat-KO mice. Bundles in P5 Gnpat-KO nerves contained large axons (asterisks), whereas in WT nerves these axons had 
been sorted (arrowhead), and the bundles contained very small-caliber axons (arrow). At P15, sciatic nerves from Gnpat-KO mice had 
Remak bundles with only 1 axon (arrowheads). Scale bars: 2 μm. (B) Composition of axon bundles in sciatic nerves from P5 WT, Pex7-KO, 
and Gnpat-KO mice. *P = 0.031; **P = 0.011. (C) Density of sorted axons in sciatic nerves from P5 WT, Pex7-KO, and Gnpat-KO mice. 
*P = 0.003. (D) Composition of Remak bundles in nerves from adult WT and Pex7-KO mice. *P = 0.013. (E) Density of unmyelinated fibers 
(UMF) in Remak bundles of nerves from adult WT and Pex7-KO mice. (F) Quantification of myelin thickness by g ratio in sciatic nerves at 
P15. Results are graphed as boxes with a line at the mean and whiskers from the minimal to maximal values. *P = 0.005. (G) DRG cocultures 
of neurons and Schwann cells from WT and Gnpat-KO mice stained for neuronal βII-tubulin (green) and for the myelin protein MBP (red). 
Scale bars: 200 μm. (H) Density of myelin segments in DRG cocultures from WT and Gnpat-KO mice. *P = 0.001. (I) Length of individual 
myelin segments in myelinating cocultures. *P = 0.001.
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4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) 
rescued the impairment in Schwann cell differentiation and 
axonal sorting of plasmalogen-deficient mice. Together, our 
novel findings reveal the neuropathology behind a deficiency 
in plasmalogens and elucidate the mechanism by which a mem-
brane phospholipid is essential for Schwann cell differentiation 
and function, implicating plasmalogens as regulators of mem-
brane and cell signaling.
Results
Plasmalogen deficiency causes defects in radial sorting and myelination. 
To assess whether Pex7- and Gnpat-KO mice had defects in PNS 
development, sciatic nerves from 5- and 15-day-old (P5 and P15, 
respectively) mice were analyzed by electron microscopy. In nerves 
from P5 WT mice, we observed axon bundles composed of small-
caliber axons (Figure 1A, arrow) and sorted axons (Figure 1A, 
arrowhead) that displayed a 1:1 relationship with Schwann cells. 
However, in sciatic nerves from P5 Gnpat-KO mice, the bundles 
contained small- and large-caliber axons (Figure 1A, asterisks). 
Consistent with a failure in the process of radial sorting, we 
observed an increased number of axons per bundle (Figure 1B) and 
a decreased number of sorted, promyelinating fibers (Figure 1C) 
in nerves from P5 Pex7- and Gnpat-KO mice. Two main conse-
quences of impaired radial sorting were observed in nerves from 
Gnpat-KO mice. In what seemed to be an attempt by Schwann cells 
to rescue the impaired radial sorting, we observed an increase in 
Schwann cells engulfing single, small-caliber axons in nerves from 
P15 Gnpat-KO mice (Figure 1A, white arrowheads). Ultrastructural 
analysis of sciatic nerves from adult Pex7-KO mice revealed a reor-
ganization of Remak bundles, since we observed a reduction in the 
number of axons in these bundles (Figure 1D), without changes 
in the density of these unmyelinated fibers (Figure 1E). Addition-
ally, the presence of large-caliber axons in Remak bundles caused 
Schwann cells to myelinate these structures (Supplemental Fig-
ure 1A; supplemental material available online with this article; 
doi:10.1172/JCI72063DS1). Surprisingly, this abnormal myelina-
tion of Remak bundles was not temporary. In sciatic nerves from 
1.5-year-old Gnpat-KO mice, we continued to observe myelina-
Figure 2
Plasmalogens and MBP coordinate myelination. (A) Quantification of myelin thickness by g ratio in sciatic nerves from 3-month-old WT and 
Pex7-KO mice. Results are the mean ± SEM. (B) X-ray diffraction analysis of sciatic nerves from WT and Pex7-KO mice. Results are graphed 
as the mean ± SEM. P = 0.01. (C) Immunofluorescence analysis of teased fibers from adult WT and Gnpat-KO nerves stained with F-actin (red). 
Arrows point to Schmidt-Lanterman incisures. Scale bars: 10 μm. (D) Immunofluorescence analysis of sciatic nerve teased fibers stained with 
an antibody against DRP2 (green) showing abnormal apposition in mutant nerves. Scale bars: 10 μm. (E) PPD-stained cross sections of sciatic 
nerves from P30 mice. Scale bars: 25 μm. (F) Quantification of the degree of myelination by g ratio in sciatic nerves from P30 mice. Results are 
graphed as boxes with a line at the mean and whiskers from the minimal to maximal values. *P < 0.001. (G) Calculated motor nerve conduction 
velocities (MNCV) in 3-month-old WT, shi, Pex7-KO, Pex7:shi DM, Gnpat-KO, and Gnpat:shi DM mice. *P < 0.0001; #P = 0.001.
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tion of Remak bundles that contained a few large-caliber axons 
(Supplemental Figure 1B).
During postnatal development, from P5 to P20, nerves from 
Pex7 and Gnpat-KO mice displayed a generalized state of hypomy-
elination (Supplemental Figure 2). Determination of the g ratio 
revealed a defect in myelination with decreased myelin thickness 
in Pex7- and Gnpat-KO–derived nerves (Figure 1F). In vitro analy-
sis of myelination using cocultures of dorsal root ganglia (DRG) 
neurons and Schwann cells (Figure 1G) revealed that Schwann 
cells from Gnpat-KO mice produced fewer and smaller myelin seg-
ments when compared with those in WT Schwann cells (Figure 1, 
H and I). These findings demonstrate that deficiency in plasmal-
ogens impairs Schwann cell function, affecting radial sorting and 
myelination and leading to PNS hypomyelination.
Plasmalogens and MBP coordinate myelination in the PNS. To further 
address the role of plasmalogens in myelination, we analyzed myelin 
content in sciatic nerves from adult Pex7-KO mice. Surprisingly, we 
observed normal myelin thickness in mutant nerves (Figure 2A), sug-
gesting a rescue of the defective myelination during postnatal devel-
opment. However, x-ray diffraction of fixed sciatic nerves showed an 
increase in myelin period of Pex7-KO nerves (Figure 2B), suggesting 
less compaction or reduced stability of myelin in the absence of plas-
malogens. The overall organization of myelinating Schwann cells in 
teased fiber preparations from Gnpat-KO nerves was abnormal, with 
an increase in noncompact myelin due to the increased number of 
Schmidt-Lanterman incisures (WT 1.7 ± 0.4 incisures/100 μm, Gnpat 
KO 4.7 ± 1.4 incisures/100 μm; P = 0.0028; Figure 2C) and with frag-
mented and dispersed DRP2-labeled appositions (Figure 2D).
We hypothesized that the achievement of myelination in the 
absence of plasmalogens could be mediated by the action of other 
myelin components. Studies of PNS myelin of shiverer (shi) mice, 
which lack MBP, a major con-
stituent of PNS myelin, showed 
that other myelin components, 
namely, P0 and P2, are com-
pensatory, allowing shi mice to 
attain normal myelination and 
compaction (24). To further 
investigate whether plasmal-
ogens were crucial for myeli-
nation, we generated Pex7:shi 
and Gnpat:shi double-mutant 
(DM) mice. Phenotypically, 
the DMs shared the features 
of Pex7- and Gnpat-KO mice 
and the characteristic shiver-
ing caused by MBP deficiency 
(data not shown). When com-
pared with single mutants and 
WT mice, nerves from Pex7:shi 
DM mice were characterized 
by a severe hypomyelination 
(Figure 2E) without axonal 
loss (WT 248,704 ± 15,639 
axons/mm2; DM 243,884 ± 
15,851 axons/mm2; P = 0.434). 
Myelin thickness was reduced 
in Pex7-KO nerves, but the dou-
ble deficiency of plasmalogens 
and MBP in Pex7:shi DM mice 
caused a pronounced defect in myelination as judged by the high 
g ratio values (Figure 2F). At the functional level, the single 
mutants had defects in nerve conduction, but in DM mice, the 
combined deficiency of MBP and plasmalogens affected nerve 
conduction by less than half the normal values (Figure 2G). These 
findings indicate that in the absence of plasmalogens, the presence 
of normal amounts of MBP (Supplemental Figure 2B) is sufficient 
to achieve normal amounts of myelin. Our results highlight the 
possible coordination between membrane phospholipids and 
myelin components to attain normal myelination and show that 
plasmalogen deficiency impairs the organization of myelin and 
myelinating Schwann cells.
Defects in plasmalogens impair regeneration and preservation of axons 
and myelin. To further investigate the role of plasmalogens in 
Schwann cells and myelin, we performed sciatic nerve crush in 
adult mice. Histological and morphometric analyses performed 
15 days after crush in the distal segment of crushed nerves from 
WT and Pex7-KO mice revealed reduced density of remyelinated 
axons in mutant nerves (Figure 3, A and B). In addition, the extent 
of remyelination was reduced, showing a higher g ratio in mutant 
nerves (Figure 3C). Our ultrastructural analysis highlighted 
that the defect in remyelination was not due to impaired axonal 
regeneration, as crushed nerves from Pex7-KO mice had a 3-fold 
increase in the density of demyelinated fibers (Figures 3, D and E), 
i.e., large-caliber axons surrounded by a Schwann cell but lacking 
myelin sheaths (Figure 3D, asterisks). These results indicate that 
plasmalogen deficiency primarily affects the ability of Schwann 
cells to remyelinate regenerating axons.
Analysis of sciatic nerves from aged Pex7- and Gnpat-KO mice 
(mean age 17 ± 3.3 months) revealed axonal loss and demyelina-
tion (Figure 4A), with decreased numbers of myelinated axons 
Figure 3
Plasmalogens are important players during remyelination of the PNS. (A) PPD-stained cross sections of 
the distal segment of sciatic nerves 15 days after nerve crush. Scale bars: 10 μm. (B) Degree of regenera-
tion as measured by the density of myelinated axons in the distal segment 15 days after sciatic nerve crush. 
*P = 0.014. (C) Extent of impaired regeneration as measured by g ratio determination. Results are graphed 
as boxes with a line at the mean and whiskers from the minimal to maximal values. *P = 0.029. (D) Electron 
microscopic analysis of the distal segment of crushed sciatic nerves from WT and Pex7-KO mice. In WT 
nerves, remyelination of regenerating axons was evident (arrowheads), whereas Pex7-KO axons of a sim-
ilar caliber were devoid of myelin (asterisks). Scale bars: 5 μm. (E) Density of axons lacking myelin (demy-
elinated axons) in the distal segment following sciatic nerve crush. Error bars represent SEM. *P = 0.012.
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(Figure 4B) and myelin loss in medium- and large-caliber axons 
(Figure 4C). Ultrastructural analysis showed axons enwrapped by 
Schwann cells but lacking myelin (Figure 4D, asterisk) and pro-
duction of redundant basal lamina by mutant Schwann cells (Fig-
ure 4D, arrowheads). The endoneurium of plasmalogen-deficient 
mice was filled with Schwann cell processes, and normal-appearing 
myelinating Schwann cells also extended processes in an apparent 
attempt to engulf and enwrap demyelinated and normally myeli-
nated axons (Supplemental Figure 3). In aged Pex7- and Gnpat-KO 
mice, attempts at remyelination by mutant Schwann cells were evi-
dent by the identification of myelinating images (Figure 4E) that 
are characteristic of the initial stages of myelination in newborn 
mice. However, the process of remyelination seemed to be ineffec-
tive and abortive, with the formation of onion bulb–like structures 
(Figure 4F) and axonal loss. Together, our results reveal that dur-
ing normal development and following nerve regeneration, plas-
malogens are crucial for Schwann cells to sort axons, myelinate, 
and to sustain axons and myelin levels in the PNS.
Plasmalogens regulate AKT activation at the plasma membrane. To 
elucidate the mechanisms underlying the effects of plasmalogen 
deficiency in Schwann cells, we analyzed key kinases in sciatic 
nerves from P15 WT and Gnpat-KO mice. Levels of phosphorylated 
c-Jun N-terminal kinase (JNK), signal transducer and activator of 
transcription 3 (STAT3), extracellular signal–regulated kinase 1/2 
(ERK1/2), and downstream targets of the GTP-binding proteins of 
the Rho family (namely, N-WASP, myosin light chain, and cofilin) 
were normal in Gnpat-KO nerves (data not shown). However, we 
observed a 3-fold decrease in AKT phosphorylation (Figure 5A) and 
in the phosphorylation of two of its targets, GSK3β (Figure 5B) 
and c-RAF (Figure 5C). The defective phosphorylation of AKT was 
unrelated to altered levels of phosphorylated PDK1 (Figure 5D) or 
PTEN (Figure 5E), two upstream regulators of AKT activation. The 
levels of phosphorylated AKT and GSK3β at Ser9 were reduced in 
nerve lysates from Gnpat-KO mice at P4 (Supplemental Figure 4, 
A and B), but were normal in lysates from Gnpat-KO mice at 
3 months of age (Supplemental Figure 4C). During the active 
period of axonal sorting, we also observed a decrease in the prolif-
eration rate of Schwann cells. Pulse-chase in vivo experiments with 
BrdU showed reduced BrdU incorporation in sciatic nerves from 
Gnpat-KO mice at P4 (Figure 5F).
Phosphorylation of AKT was also impaired in serum-starved 
mouse embryonic fibroblasts (MEFs) from Gnpat-KO mice after 
stimulation with 10% FBS (Figure 5G and Supplemental Fig-
ure 4D). However, FBS stimulation was able to normally acti-
vate ERK1/2 in serum-starved MEFs from KO mice (Figure 5G 
and Supplemental Figure 4E). We next investigated whether the 
NRG1/ErbB signaling pathway would also be affected by the 
plasmalogen deficiency. We measured the levels of AKT phos-
phorylation in primary Schwann cells from WT and Gnpat-KO 
mice after stimulation with NRG1, the endogenous axonal sig-
nal that regulates Schwann cell differentiation and myelination 
(18). We detected decreased levels of phosphorylation, indicative 
of impaired AKT activation in Schwann cells from Gnpat-KO 
mice (Figure 5, H and I). The recruitment of AKT to the plasma 
membrane plays a critical role in its activation by PDK1 and by 
the mammalian TOR complex 2 (25, 26). Compared with WT 
MEFs, the plasmalogen deficiency in Gnpat-KO MEFs impaired 
the FBS-induced phosphorylation of AKT at the membrane (Fig-
ure 5J and Supplemental Figure 4F), despite normal levels and 
localization of PDK1 (Supplemental Figure 4G). Failure to acti-
vate AKT at the membrane was also evident by the decreased levels 
of phosphorylated AKT in the cytosolic fraction (Figure 5J). To 
Figure 4
Deficiency in plasmalogens impairs the ability of Schwann cells to sustain myelinated axons. (A) PPD-stained cross sections of sciatic nerves 
from 1.5-year-old WT and Pex7-KO mice revealing demyelination and loss of axons in mutant nerves. Scale bars: 10 μm. (B) Density of myeli-
nated axons in sciatic nerves from WT and Pex7-KO mice. Error bars represent SEM. *P = 0.012. (C) Quantification of the degree of myelination 
by g ratio in sciatic nerves from 1.5-year-old WT and Pex7-KO mice. *P = 0.026. Error bars represent SEM. (D) Electron microscopic analysis of 
sciatic nerves from representative 1.5-year-old WT and Pex7-KO mice showing an axon devoid of myelin (asterisk), severely demyelinated axons 
(arrows), and the presence of extended Schwann cell processes (arrowheads) throughout the perineurium. Scale bars: 2 μm. (E) Schwann cell 
from an aged Gnpat-KO mouse undergoing remyelination of a demyelinated axon. Scale bar: 2 μm. (F) Engulfment of a demyelinated axon by 
2 Schwann cells, generating concentric deposition of membrane processes, similar to the formation of onion bulbs. Scale bar: 2 μm.
Downloaded from http://www.jci.org on January 19, 2018.   https://doi.org/10.1172/JCI72063
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 6   June 2014 2565
Figure 5
Defects in plasmalogens result in impaired AKT activation and signaling. (A) Western blot analysis and quantification of AKT phosphorylation (p-AKT) 
in sciatic nerve lysates of P15 WT and Gnpat-KO mice. *P = 0.018; **P = 0.006. (B–E) Quantification of phosphorylated forms of GSK3β at Ser9 
(B), c-RAF at Ser259 (C), PDK1 at Ser241 (D), and PTEN at Ser380 (E) in sciatic nerves from WT and Gnpat-KO mice. *P < 0.02. (F) Density of 
BrdU-positive cells in nerves from P4 WT and Gnpat-KO mice. *P = 0.020. (G) Western blot analyses of p-AKT and p-ERK1/2 in serum-starved 
MEFs from WT and Gnpat-KO mice stimulated with 10% FBS. (H and I) Quantification of p-AKT at Ser473 (H) and Thr308 (I) in primary WT and 
Gnpat-KO Schwann cells after stimulation with NRG1. (J) Western blot analysis of total and p-AKT in cytosolic and membrane fractions of serum-
starved MEFs from WT and Gnpat-KO mice stimulated with 10% FBS. Western blot analysis of caveolin 1 (CAV1), GAPDH, and peroxisomal thiolase 
(ACAA1) used to control membrane fractions and cytosolic fractions and to monitor lack of solubilized organelles in cytosolic fractions, respectively. 
(K) DRG cocultures from WT and Gnpat-KO mice treated with DMSO (control) or with SC79, stained for neuronal βIII-tubulin (green) and MBP (red). 
Scale bars: 100 μm. (L) Density of myelin segments in DRG cocultures from WT and Gnpat-KO mice after DMSO and SC79 treatment. *P < 0.002. 
(M) Length of individual myelin segments in myelinating cocultures. *P < 0.01. Error bars represent SEM in all graphs.
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determine whether the defect in AKT activation plays a critical 
role in the impaired myelination observed in DRG cocultures, we 
performed in vitro myelination assays in the presence of SC79. 
This small compound was shown to allow AKT activation in the 
cytosol, bypassing the need for AKT to be targeted to the mem-
brane (27). Treatment of DRG cocultures from Gnpat-KO mice 
with SC79 (Figure 5K) increased the number and length of myelin 
segments (Figure 5, L and M), indicating the rescue in myelina-
tion. These results highlight that plasmalogens are important for 
the correct recruitment and activation of AKT at the membrane 
and that their absence causes a signaling defect independently of 
ligand-receptor activation.
Defective differentiation of Schwann cells in plasmalogen-deficient 
mice is rescued by treatment with GSK3β inhibitors. AKT promotes 
Schwann cell differentiation and myelination in part through 
the inhibitory phosphorylation of GSK3β at Ser9 (28). We there-
Figure 6
Treatment with GSK3β inhibitors restores Schwann cell differentiation and radial sorting defects. (A) In vitro myelination after treatment with NaCl 
(control) or LiCl. *P = 0.001. (B) Strategy for in vivo treatments. For the assessment of LiCl on the phosphorylation of AKT and GSK3β, mice were 
injected with LiCl on alternating days from P7 to P15 (upper diagram). For the assessment of LiCl on nerve pathology, mice were injected daily 
with LiCl from P1 to P6 (lower diagram). (C and D) Quantification of p-GSK3β at Tyr216 (*P = 0.04) (C) and Ser9 (*P = 0.017) (D) in nerves from 
P15 mice. (E and F) Quantification of p-AKT at Ser473 (E) and Thr308 (F) in nerves from P15 mice. *P = 0.01. (G and H) Quantification of SOX2 
(G) and OCT6 (H) levels in nerves from P6 WT and Gnpat-KO mice. *P = 0.03 (G); P = 0.038 (H). (I) Ultrastructural analysis of sciatic nerves from 
P6 Gnpat-KO mice treated with NaCl and LiCl. Lines and asterisks indicate axon bundles on control and lithium-treated nerves, respectively. Scale 
bars: 5 μm. (J) Number of axons in bundles of sciatic nerves from P6 mice treated with NaCl and LiCl. *P = 0.0013. (K) Density of sorted axons 
(promyelinating stage) in sciatic nerves from P6 mice treated with NaCl and LiCl. *P = 0.0022. (L) Number of axons in bundles of sciatic nerves 
from P4 mice treated with DMSO and TDZD-8. *P < 0.007. (M) Density of sorted axons in sciatic nerves from P4 WT and Gnpat-KO mice treated 
with DMSO and TDZD-8. *P < 0.03.
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fore tested whether treatment with LiCl, a GSK3β inhibitor (29), 
would rescue the Schwann cell defects observed in Gnpat-KO 
mice. The addition of LiCl to the culture medium rescued the 
myelination defect of DRG mixed cultures from Gnpat-KO mice 
(Figure 6A). Therefore, we treated WT and Gnpat-KO mice with 
LiCl or NaCl in two treatment schemes (Figure 6B). Follow-
ing LiCl treatment for 1 week from P7, analysis of nerves from 
Gnpat-KO mice revealed decreased phosphorylation of GSK3β at 
Tyr216 (Figure 6C) and increased phosphorylation of GSK3β at 
Ser9 (Figure 6D). We found that higher levels of GSK3β phos-
phorylation at Ser9 were due to increased phosphorylation 
of AKT (Figure 6, E and F), since lithium dissociates the pro-
tein phosphatase 2A–containing (PP2A-containing) complex, 
decreasing the dephosphorylation of AKT (30).
Lithium treatment during the first 6 days of life induced 
Schwann cell differentiation in Gnpat-KO nerves, as levels of 
SOX2, a marker of immature Schwann cells, were decreased 
(Figure 6G), and levels of OCT6, a marker of differentiated 
Schwann cells, were increased (Figure 6H). Ultrastructural 
analysis of sciatic nerves from LiCl-treated Gnpat-KO nerves 
showed improved myelination (Figure 6I) and rescue in 
axonal sorting, with normal numbers of axons in bundles 
(Figure 6J) and normal density of sorted promyelinating 
Schwann cells containing a single axon (Figure 6K). Simi-
lar results were obtained when newborn WT and Gnpat-KO 
mice were treated for 4 days with TDZD-8, a highly specific 
inhibitor of GSK3β (31). In sciatic nerves from P4 Gnpat-
KO mice treated with TDZD-8, we observed a decrease in 
the number of axons per bundle (Figure 6L) and an increase 
in the number of sorted axons (Figure 6M). Taken together, 
our results indicate that plasmalogen deficiency affects 
Schwann cell differentiation and function, causing defects 
in axonal sorting, myelination, assembly of myelin, and 
nerve conduction through the impairment of AKT activa-
tion at the plasma membrane and via GSK3β.
Discussion
In this study, we report that a plasmalogen defect in the PNS 
primarily affects Schwann cells and that plasmalogens are 
crucial for Schwann cells at two developmental time points. 
During the early postnatal period, plasmalogens are important 
for axon-glia interaction and the myelination process. The rec-
ognition of axons by Schwann cells or the ability to actively 
segregate axons destined for myelination is impaired by the 
deficiency in plasmalogens. The presence of unsorted axons 
caused abnormal myelination of the Remak bundles and reor-
ganization of these structures. Additionally, impaired myelina-
tion, increased regions of noncompact myelin, and defective 
compartmentalization of Schwann cells in mutant nerves 
highlight the role of plasmalogens in the correct assembly of 
myelin and the organization of Schwann cells. Surprisingly, the 
extent of myelin thickness was normal in adult mutant mice, 
which led us to hypothesize, that like a deficiency in MBP, 
which has minimal effects in the PNS despite the complete lack 
of myelin in the CNS, other myelin components may contrib-
ute to achieving normal myelination (24, 32). MBP, known to 
modulate the apposition of the cytoplasmic leaflets of myelin 
membranes through electrostatic interactions, is also involved 
in the partition of myelin into compact and noncompact mye-
lin (33). To further investigate the role of plasmalogens during 
myelination, we asked whether depleting myelin of plasmalo-
gens and MBP, two major constituents of myelin at the cytoplas-
mic apposition, would impair myelination. In DM mice, we found a 
major impairment in myelination and nerve conduction, indicating 
that plasmalogens are important regulators of myelination. In addi-
tion, we found that upon Wallerian degeneration, injury-induced 
remyelination was also affected by the deficiency in plasmalogens, 
although axonal regeneration seemed to be unaffected. Failure to 
maintain myelin levels was also evident in sciatic nerves from aged 
mutant mice, in which we observed extensive demyelination, axonal 
loss, and failed attempts to remyelinate the PNS.
Our results highlight that in mice, a deficiency in plasmalogens 
is sufficient to impair PNS myelination and to cause age-depen-
dent peripheral neuropathy. As such, the evaluation of the PNS 
Figure 7
Schematic representation of a proposed model depicting the conse-
quences of plasmalogen deficiency in the PNS. The deficiency in plasmal-
ogens at the plasma membrane of Schwann cells causes reduced phos-
phorylation of AKT, leading to an overt activation of GSK3β by reducing 
the inhibitory phosphorylation at Ser9. Active GSK3β inhibits Schwann cell 
differentiation, impairing axonal sorting and myelination. Lithium admin-
istration to inhibit GSK3β is able to rescue Schwann cell differentiation 
and maturation in the absence of plasmalogens. During aging, lack of 
plasmalogens causes demyelination and axonal loss, and Schwann cells 
extend processes in failed attempts to remyelinate existing axons. Plasmal-
ogens are depicted by gray-colored phospholipids; ҂, impaired signaling; 
→, induction; ┬, inhibition.
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on restoring plasmalogen levels in nervous tissue (39). As such, 
improving the defective AKT/GSK3β signaling pathway may have 
clinical potential in combined therapeutic interventions with 
alkyl-glycerol during the active period of PNS myelination and in 
mildly affected patients displaying signs of peripheral neuropathy.
In summary, our data reveal the role of plasmalogens in the neu-
ropathic course of two models of RCDP (see proposed model in 
Figure 7), showing that plasmalogen deficiency severely impairs 
the ability of Schwann cells to differentiate and mature, thus caus-
ing defects in myelination and nerve conduction. Through the 
identification of the mechanism by which a defect in plasmalogens 
mediates the pathology, we unraveled that ether phospholipids are 
crucial for the activation of the AKT pathways and identified a 
candidate therapeutic intervention that overcomes the plasmal-
ogen deficiency and rescues the signaling pathway and Schwann 
cell differentiation.
Methods
Mouse strains, procedures, and treatments. WT, Pex7, and Gnpat mice have been 
previously described (9, 10). KO and WT littermates of both sexes were 
obtained from mating of heterozygous mice. Shiverer mice (shi; Mbpshi/J) 
were obtained from The Jackson Laboratory. Pex7:shi and Gnpat:shi DM 
mice were obtained from F2 mice after crossing heterozygous Pex7 or Gnpat 
mice with homozygous shi mice.
For nerve crush, 2-month-old WT (n = 4) and Pex7-KO (n = 6) mice were 
anesthetized (i.p. 100 mg/kg ketamine and 1 mg/kg medetomidine), and 
the exposed right sciatic nerve was injured (15-second crush 2 times) at the 
level of the notch with a fine hemostat. The contralateral nerve was used as 
a control. Postsurgical analgesia (1 mg/kg butorphanol s.c.) was performed 
twice a day for 3 days. Nerve conduction (WT, n = 6; shi, n = 4; Pex7-KO, n = 3; 
Pex7:shi DM, n = 4; Gnpat-KO, n = 5; Gnpat:shi DM, n = 3) was determined as 
previously described (44).
For the BrdU incorporation assay, BrdU in 0.9% NaCl and 7 mM NaOH 
were injected i.p. at a dosage of 50 mg/kg in WT and Gnpat-KO mice (n = 4 
for each genotype) 4 and 20 hours before the collection of sciatic nerves.
LiCl or NaCl at a dosage of 50 mg/kg was injected s.c. daily from P0.5 to 
P6 (control WT, n = 6; Gnpat-KO, n = 6; lithium WT, n = 7; Gnpat-KO, n = 6) 
or on alternating days from P7 to P15 (control WT, n = 7; Gnpat-KO, n = 7; 
lithium WT, n = 7; Gnpat-KO, n = 7). TDZD-8 (Sigma-Aldrich) at 5 mg/kg or 
DMSO at 20% (v/v) was injected s.c. daily from P0.5 to P4 (control WT, n= 4; 
Gnpat-KO, n = 4; TDZD-8 WT, n = 5; Gnpat-KO, n = 5). Mice were used under 
standard conditions and had free access to food and water. Experiments 
and mouse manipulations were performed in compliance with the institu-
tional guidelines and recommendations of the Federation for Laboratory 
Animal Science Association (FELASA) and were approved by the National 
Authority for Animal Health (DGAV; Lisbon, Portugal).
Histological and morphological analyses. Sciatic nerves were dissected and 
fixed by immersion on 4% glutaraldehyde in 0.1 M cacodylate buffer (pH 
7.4) for 1 week. After postfixation with 1% OsO4 in 0.1 M cacodylate buffer 
(pH 7.4) for 2 hours, nerves were dehydrated and embedded in Epon (Elec-
tron Microscopy Sciences). Sections (1-μm-thick) were stained for 10 min-
utes with 1% p-phenylenediamine (PPD) in absolute methanol, dried, and 
mounted on a drop of DPX (Merk). The entire area of the nerve was pho-
tographed on an Olympus optical microscope equipped with an Olympus 
DP 25 camera and Cell B software, and images were imported into Photo-
shop (Adobe). For g ratio analyses, the Photoshop recording measurement 
tool was used to determine the area of the axon and the entire myelinated 
fiber (axon plus myelin). Derived diameters were used to calculate the g 
ratio in 200 to 300 individual fibers per genotype and age (P5 mice: WT, 
n = 7; Pex7-KO, n = 4; Gnpat-KO, n = 4; P15 mice: WT, n = 5; Pex7-KO, n = 4; 
in RCDP type 2 and type 3 patients should be informative. In Ref-
sum’s disease, the single defect in α–oxidation of phytanic acid is 
known to cause peripheral neuropathy (34). Previously, we identi-
fied a group of atypical RCDP type 1 patients with mild mutations 
in PEX7 and a Refsum-like presentation, which included retinitis 
pigmentosa and nerve hypertrophy (17). In addition to the accu-
mulation of phytanic acid, these patients also had a defect in plas-
malogen synthesis. Based on our current findings, we propose that 
RCDP type 1 patients should also be investigated for defects in 
nerve conduction and pathology. In these patients, the peripheral 
neuropathy can be aggravated by the combined defect in plasmal-
ogen synthesis and phytanic acid accumulation.
In the present study, we analyzed the phosphorylation levels of 
several kinases involved in PNS development to understand how 
a defect in plasmalogens impairs Schwann cell differentiation and 
Schwann cell–mediated myelination. The results obtained in nerves 
of Gnpat-KO mice during the active period of myelination in the 
PNS revealed an impairment of AKT activation. Our observations 
of impaired activation of the AKT pathway following induction 
with FBS or NRG1, which was not mediated by defects in upstream 
regulators, suggested a more direct role of plasmalogens in AKT 
activation rather than of multiple defects in several ligand-receptor 
interactions and activations. AKT activation by phosphorylation at 
the plasma membrane was impaired in plasmalogen-deficient cells. 
In mutant cells, AKT was found in membrane fractions, but upon 
FBS stimulation, AKT was not phosphorylated despite the correct 
localization and phosphorylation of PDK1. The requirement of 
AKT to associate with raft microdomains for efficient activation 
and signal transduction, combined with the enrichment of plas-
malogens in lipid rafts, suggests that the defect in plasmalogens 
affects the correct compartmentalization of AKT, and thus its 
activation by phosphorylation (25, 34). The AKT signaling path-
way is important for lens fiber differentiation, chondrocyte dif-
ferentiation and maturation, adipogenesis, and spermatogenesis 
(35–38). Based on our results showing that a plasmalogen defect 
impairs AKT activation in Schwann cells, we hypothesize that in 
tissues affected by a plasmalogen defect (e.g., lens, cartilage, adipo-
cytes, and testis), impaired AKT signaling  modulates the observed 
pathology, namely, cataracts, impaired ossification, lipodystrophy, 
and loss of spermatocytes (39).
In sciatic nerves from Gnpat-KO mice, we found that impaired 
AKT activation resulted in dysregulated phosphorylation of 
GSK3β. GSK3β activity and its role in the regulation of transcrip-
tion are known to modulate Schwann cell differentiation and 
myelination (28, 40). Active GSK3β, phosphorylated at Tyr216, 
is inhibited by AKT phosphorylation at Ser9 (41). In nerves from 
Gnpat-KO mice, we observed increased levels of Tyr216 phospho-
rylation and decreased levels of Ser9 phosphorylation, which, 
combined, indicate overtly active GSK3β (41). Lithium, a known 
inhibitor of GSK3β, can directly inhibit the kinase through Mg2+ 
competition and can indirectly inhibit GSK3β by promoting fur-
ther inhibition through Ser9 phosphorylation (42, 43). Lithium 
administration to Gnpat-KO mice was able to normalize GSK3β 
phosphorylation status, induced the stimulation of Schwann cell 
differentiation, rescued the radial sorting defect, and improved 
myelination independently of the plasmalogen defect. Similar 
findings were obtained when Gnpat-KO mice were treated with 
TDZD-8, a highly specific inhibitor of GSK3β. Treatment of plas-
malogen-deficient mice with alkyl-glycerol rescues the biochemi-
cal defect and pathology in several tissues, but has minimal effects 
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lyzed by epifluorescence on a Zeiss Axio Imager Z1 microscope equipped 
with an Axiocam MR3.0 camera and Axiovision 4.7 software.
For teased fiber preparations, sciatic nerves from 9-month-old WT 
and Gnpat-KO mice (n = 3 for each genotype) were dissected and fixed 
by immersion with 4% PFA in PBS for 30 minutes. Under a dissection 
microscope, the perineurium was removed, and small nerve bundles were 
separated using 30-gauge needles. Nerve bundles were blocked and per-
meabilized by incubation for 1 hour at RT in blocking buffer containing 
0.1% Triton X-100. Bundles were incubated with rhodamine-conjugated 
phalloidin (1:400; Invitrogen) or with rabbit anti-DRP2 (46) for 16 hours 
at 4°C. After washing with PBS, bundles were incubated for 2 hours at RT 
with secondary antibodies. Nerve bundles were then washed in PBS and 
placed in a drop of Vectashield containing DAPI. Single teased fibers were 
prepared using 30-gauge needles, sealed, and viewed by confocal micros-
copy on a Leica TCS SP5 II.
Biochemical analyses. For Western blot analysis, lysates of sciatic nerves 
were prepared by sonication in lysis buffer, and 25 μg protein was run on 
12% SDS-PAGE gels. Blots were developed with ECL (Pierce) and exposed 
to Hyperfilm (Amersham). Films were scanned on a Molecular Imager 
GS800, and Quantity One (Bio-Rad) was used for quantifications. The Pro-
teoExtract subcellular proteome extraction kit (Calbiochem) was used to 
obtain membrane and cytosolic fractions of cultured MEFs from WT and 
Gnpat-KO mice. Three independent experiments were performed.
X-ray diffraction. Sciatic nerves from WT (n = 6) and Pex7-KO (n = 7) mice 
were fixed by immersion on 2% glutaraldehyde in 0.12 M phosphate buf-
fer (pH 7.4). Diffraction experiments and data analysis were carried out as 
detailed previously (47). For the determination of the relative amount of 
myelin by x-ray diffraction, the quotient M/M+B was used, in which the 
denominator includes the total x-ray scatter coming from the volume of 
nerve subtended by the x-ray beam (consisting of the multilamellar myelin, 
M, and background, B), and the numerator is the total intensity coming 
from the multilamellar myelin (the peak intensities above background), as 
previously described (47).
Statistics. Results were expressed as the mean ± SEM, and data were ana-
lyzed with Prism software (GraphPad Software). To compare 2 groups, 
nonparametric Mann-Whitney U tests were used, and P < 0.05 was consid-
ered a significant difference. For comparison of more than 2 groups, 1-way 
ANOVA tests were used, followed by Tukey’s multiple comparison tests.
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Gnpat-KO, n = 4; P30 and P90, n = 4 for all genotypes; 1.5-year-old: WT, 
n = 6; Pex7-KO, n = 6; Gnpat-KO, n = 5). For the determination of the density 
of myelinated fibers (MFs), the total number of MFs was divided by the 
area of the entire cross section of the sciatic nerve.
Ultrathin sections (60-nm) prepared on a Leica ultramicrotome were placed 
on 200-mesh copper grids (Electron Microscopy Sciences) and were coun-
terstained, first with alcoholic uranyl acetate solution (2% w/v; 10 minutes), 
then by aqueous uranyl acetate solution (2% w/v; 10 minutes) and lead citrate 
(4% w/v; 10 minutes). Grids were observed on a JEOL JEM-1400 transmission 
electron microscope equipped with an Orious Sc1000 digital camera. Ten to 
15 nonoverlapping images were obtained and used for all determinations.
Cell culture and in vitro myelination. MEFs were prepared from E12 
embryos and cultured in high-glucose DMEM with 10% FBS and anti-
biotics. Primary Schwann cells were isolated from sciatic nerves of 4-day-
old WT and Gnpat-KO mice and cultured in high-glucose DMEM with 
10% normal horse serum (NHS) and antibiotics. Schwann cells were 
serum starved for 12 hours before stimulation with 30 ng/ml recombi-
nant human neuregulin 1 β EGF-like domain (R&D Systems). The lysates 
were prepared after 0, 7, and 15 minutes at 37°C. Serum-starved MEFs 
were stimulated with 10% FBS for 0, 1, 3, and 5 minutes. The lysates 
were prepared in PBS containing 0.3% Triton X-100, protease inhibitors 
(cOmplete, Mini; Roche), and 2 mM orthovanadate.
In vitro myelination was performed as described (45). Mixed cultures 
of DRG neurons and Schwann cells from WT (n = 7) and Gnpat-KO 
(n = 4) embryos were maintained in high-glucose MEM with 2 mM 
L-glutamine, 10% FBS, 50 ng/ml nerve growth factor (NGF) (2.5S; Millipore), 
and 1% penicillin-streptomycin, and were then plated onto 13-mm-diameter 
Matrigel-coated coverslides (1:10 in DMEM). After 24 hours at 37°C, 
cells were cultured for 10 days in neurobasal medium supplemented with 
4 g/l glucose, 2 mM L-glutamine, 50 ng/ml NGF, and 1× B27 (Gibco). 
Myelination was induced at 10 days in vitro (div) by the daily addition of 
50 μg/ml ascorbic acid to high-glucose MEM medium supplemented with 
2 mM L-glutamine, 10% FBS, and 50 ng/ml NGF. For lithium treatment 
in myelination assays, medium was supplemented with 3 μM forskolin and 
16 mM NaCl (control) or 16 mM LiCl starting at div 7. For treatment with 
SC79, medium was supplemented with 0.0008% v/v DMSO or with 0.4 μg/ml 
SC79 (Millipore) in DMSO starting at div 7. In both treatment schemes, 
cells were fixed and processed for immunofluorescence at 20 div.
Antibodies. The antibodies used were: anti–βIII-tubulin (1:600; 1967-1; 
Epitomics); anti-MBP (1:250; MAB386; Millipore); anti-DRP2 
(1:1,000; ref. 46); anti–Ser473-AKT; anti–Thr308-AKT; anti–pan-AKT; 
anti–Ser259-c-RAF; anti–Ser9-GSK3β (all at 1:1,000; catalog 9916; Cell Sig-
naling Technology); anti–β-tubulin (1:1,000; catalog 5142; Cell Signaling 
Technology); anti–caveolin 1 (1:5,000; C13630; BD Transduction Labora-
tories); anti-ACAA1 (1:1,000; HPA007244; Sigma-Aldrich); anti-GAPDH 
(1:1,000; catalog 5174; Cell Signaling Technology); and anti-BrdU (1:2,000; 
Ab6326; Abcam). For immunofluorescence, Alexa Fluor 488– and Alexa 
Fluor 568–conjugated secondary antibodies were used (1:500; Invitrogen). 
For detection of BrdU, nerves from P4 WT and Gnpat-KO mice were fixed 
in carnoys and processed for immunofluorescence in paraffin sections pre-
treated with 2N HCl. For Western blotting, horseradish peroxidase–conju-
gated secondary antibodies were used (1:5,000; Jackson ImmunoResearch).
Immunofluorescence. In the in vitro myelination assays, fixed and perme-
abilized cells were incubated for 1 hour at room temperature (RT) with 
blocking buffer (5% normal donkey serum [NDS] in PBS). Primary anti-
bodies (rabbit anti–βIII-tubulin and rat anti-MBP) were diluted in block-
ing buffer and incubated for 16 hours at 4°C. After washing with PBS, 
secondary antibodies were diluted in blocking buffer and incubated for 
1 hour at RT. After washing, coverslides were mounted on microscope 
slides with Vectashield containing DAPI (Vector Labs). Slides were ana-
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